Serum Oxidative Stress Markers are not Associated with Renal and Common Carotid Arteries Arteriosclerotic Vascular Changes in Patients with Gout

1. Krishnan E. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 2010; 49(7):1229-38.10.1093/rheumatology/keq03720202928Search in Google Scholar

2. Yang X, Li Y, Ren X et al. Oxidative stress – Mediated Atherosclerosis: Mechanisms and Therapies. Front Physiol. 2017;8:600. doi: 10.3389/fphys.2017.0060.Search in Google Scholar

3. Wilcox C, Araujo M. Antioxid. Redox Signal. 2014, 2011(1):74-101.Search in Google Scholar

4. Nageswara R, Vendrov MA, Runge MS. Oxidative stress and vascular disease. Atherosclerosis, Thrombosis and Vascular biology. 2005; 25:29-38.10.1161/01.ATV.0000150649.39934.1315539615Search in Google Scholar

5. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008; 27(6):608-619.Search in Google Scholar

6. Neogi T, Jansen TLT, Dalbeth N et al. Gout classification criteria. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheumatol 2015; 67:2557-2568.10.1002/art.39254456615326352873Search in Google Scholar

7. Shi H, Sui Y, Wang X et al. Hydroxyl radical production and oxidative damage induced by cadmium and naphthalene in liver of Carassius auratus Comp. Biochem and Physiol. Part C: Toxicol and Pharmacol. 2005; 140:115-121.Search in Google Scholar

8. Yoshioka T, Iwamoto N. Ito K. An application of Electron Paramagnetic Resonance to evaluate nitric oxide and its quenchers. J Am Soci Nephrol. 1996;7:961-965.10.1681/ASN.V769618793807Search in Google Scholar

9. Yokoyama K, Hashiba K, Wakabayashi H et al. Inhibition of LPS-stimulated NO production in mouse macrophage-like cells by Tropolones. Anticans res. 2004; 24:3917-3922.Search in Google Scholar

10. Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 2014; 32:149-153.10.1097/HJH.0b013e328365b29c386802624172238Search in Google Scholar

11. Staub D, Meyerhans A, Bundi B et al. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 2006; 37:800-805.10.1161/01.STR.0000202589.47401.c616439703Search in Google Scholar

12. Frauchinger B, Schmid HP, Roedel C et al. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 2001; 32:836-841.10.1161/01.STR.32.4.836Search in Google Scholar

13. Cippoli JA, Ferreira-Sae MC, Martins RP et al. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovascular Disorders. 2012;12:52. doi 10.1186/1471-2261-12-52.10.1186/1471-2261-12-52341819322800461Open DOISearch in Google Scholar

14. Montalcini T, Gorgone G, Gazzaruso C, et al. Relation between serum uric acid and carotid intima-meida thickness in healthy postmenopausal women. Intern Emerg Med. 2007; 2(1):19-23.10.1007/s11739-007-0004-3278060617551679Search in Google Scholar

15. Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with intima-media thickness in patients with hypertension. Atherosclerosis. 2008; 197(1):159-163.10.1016/j.atherosclerosis.2007.03.00817416371Search in Google Scholar

16. Messerli F, Christie B, de Carvalho JGR, et al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980; 93(6):817-821.10.7326/0003-4819-93-6-8177447188Search in Google Scholar

17. Çukurova S, Pamuk ÖN, Ünlü E, et al. Subclinical atherosclerosis in gouty arthritis patients: a comparative study. Rheumatol Int. 2012; 32(6):1769-73.10.1007/s00296-011-1900-421442166Search in Google Scholar

18. Gancheva R, Koundurdjiev A, Ivanova M et al. Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography. Rheumatol Int. 2017; 37(1):121-130.10.1007/s00296-016-3556-627577941Search in Google Scholar

19. Schulz E, Gori T, Muntel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 2011; 34: 665-73.10.1038/hr.2011.3921512515Search in Google Scholar

20. Bake JR, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118(8):816-26.Search in Google Scholar

21. Neogi T, George J, Rekhraj S et al. Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum. 2012;64(2):327-38.10.1002/art.33369326568321953377Search in Google Scholar

22. Corry DB, Eslami P, Yamamoto K et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renini-angiotensin system. J. Hypertens 2008; 26:269-75.10.1097/HJH.0b013e3282f240bf18192841Search in Google Scholar

23. Kato M, Hisatone I, Tomikura Y, et al. Status of endothelial dependent vasodilatation in patients with hyperuricemia. Am. J Cardiol 2005; 96:1576-8.10.1016/j.amjcard.2005.07.06816310444Search in Google Scholar

24. Patterson RA, Horsley ET, Leake DS. Prooxidant and anti-oxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res 2003; 44:512-21.10.1194/jlr.M200407-JLR20012562831Search in Google Scholar

25. Terkeltaub R. Gout: a variable inflammatory disease. Ann Rheum Dis. 2016; 75(2):30.Search in Google Scholar

26. Zamudio-Cuevas Y, Hernández-Díaz C, Pineda C et al. Molecular basis of oxidative stress in gouty arthropathy. Clin Rheumatol. 2015(10):1667-72.10.1007/s10067-015-2933-y25854697Search in Google Scholar

27. Stamp LK, Turner R, Khalilova IS et al. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricemia. Rheumatology 53(11):1958-1965.10.1093/rheumatology/keu21824899662Search in Google Scholar

28. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric aicd and oxidative stress. Curr Pharm Des. 2005; 11(32):4145-51.10.2174/13816120577491325516375736Search in Google Scholar